Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -35.98% is 55% above its 2-year average of -80.81%, near the high end of its 2-year range (-190.22%–-10.39%).
As of the fiscal period ended Tuesday, June 30, 2026. 54.68% above its 12-month average of -79.39%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -35.98%.
RETURN ON INVESTED CAPITAL (ROIC)
-35.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-79.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+54.68%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-0.94%
vs the sector median at left
OnKure Therapeutics, Inc.
Market Cap
$99.62M
Return on Invested Capital (ROIC)
-35.98%
TTM Avg
-79.39%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.94M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.90M
Return on Invested Capital (ROIC)
13.49%
TTM Avg
-178.47%
3Y Avg
-181.87%
5Y Avg
-147.13%
Market Cap
$101.36M
Return on Invested Capital (ROIC)
5.11%
TTM Avg
-4.38%
3Y Avg
-1.84%
5Y Avg
2.15%
Market Cap
$97.14M
Return on Invested Capital (ROIC)
-50.17%
TTM Avg
-64.75%
3Y Avg
-64.53%
5Y Avg
-48.29%
Market Cap
$102.75M
Return on Invested Capital (ROIC)
-82.35%
TTM Avg
-77.56%
3Y Avg
-62.72%
5Y Avg
-68.20%
Market Cap
$103.14M
Return on Invested Capital (ROIC)
-47.54%
TTM Avg
-30.79%
3Y Avg
-47.42%
5Y Avg
-44.72%
Market Cap
$95.14M
Return on Invested Capital (ROIC)
-49.27%
TTM Avg
-62.42%
3Y Avg
-75.33%
5Y Avg
-62.43%
Market Cap
$104.26M
Return on Invested Capital (ROIC)
41.64%
TTM Avg
-39.48%
3Y Avg
-25.23%
5Y Avg
-17.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $99.62M | -35.98% | -79.39% | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.90M | 13.49% | -178.47% | -181.87% | -147.13% |
| The Joint Corp. (JYNT)vs › | $101.36M | 5.11% | -4.38% | -1.84% | 2.15% |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | -50.17% | -64.75% | -64.53% | -48.29% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | -82.35% | -77.56% | -62.72% | -68.20% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | -47.54% | -30.79% | -47.42% | -44.72% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | -49.27% | -62.42% | -75.33% | -62.43% |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 41.64% | -39.48% | -25.23% | -17.21% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | -47.75% | -127.40% | -174.63% | -174.63% |
ROIC
-36.0%
ROE
-34.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -35.98% |
| 2026-03-31 | -33.39% |
| 2025-12-31 | -112.02% |
| 2025-09-30 | -124.08% |
| 2025-06-30 | -91.48% |
| 2025-03-31 | -76.63% |
| 2024-12-31 | -60.01% |
| 2024-09-30 | -10.39% |
| 2024-06-30 | -190.22% |
| 2024-03-31 | -95.10% |
| 2023-12-31 | -59.64% |
